NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000007820

Registered date:23/04/2012

A Randamized, Prospective and Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedUveitic Glaucoma
Date of first enrollment2008/02/01
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Latanoprost eye drop Timolol-XE eye drop

Outcome(s)

Primary Outcomeintraocular pressure-lowering ratio
Secondary Outcome1)flare value in the anterior chamber 2)side effects(conjunctival injection, corneal erosion) 3)macular thickness measured by OCT

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) herpetic iritis 2) PAS index>25% (secondary angle closure glaucoma) 3) The patients who received Argon Laser Trabeculoplasty within 3 months. 4) The patients who received intraocular surgeries within 6 months. 5)The patients who had asthma or arrythmia, and couldn't receive timolol.

Related Information

Contact

public contact
Name Toshikatsu Kaburaki
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan Japan
Telephone 03-3815-5411
E-mail kabutosi-tky@umin.ac.jp
Affiliation University of Tokyo Hospital Ophthalmology
scientific contact
Name Toshikatsu Kaburaki
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan Japan
Telephone 03-3815-5411
E-mail kabutosi-tky@umin.ac.jp
Affiliation University of Tokyo Hospital Ophthalmology